NIS 113 million for biodevices R&D

Israel’s Innovation Authority is allocating NIS 113 million for a new research and development center for startups to build biodevices based on biochips. This area is known as bio-convergence and is expected to be a growth engine and source of diversification for Israeli industry.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *